RxDoctor Payments Data

Abdullah Al Ghamdi, MD

Critical Care Medicine · Westlake, OHNPI 1710119532

Payments from drug & device makers

$691in general payments, 2019–2025

Across 15 payments — averaging $46.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$368
  • Abiomed$224
  • Biogen$71
  • Bard Access Systems, Inc.$14
  • Sanofi$13

What the payments were for

  • Food & beverage$691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson10$368
Abiomed2$224
Biogen1$71
Bard Access Systems, Inc.1$14
Sanofi1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$691 in reported general payments places this provider in the 70th percentile of 285 critical care medicine providers in Ohio.

See all critical care medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$365,069
Medicare patients
563
Services billed
2,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,189

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Westlake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →